What This Top Dividend Portfolio Is Holding Now: GlaxoSmithKline plc, Centrica PLC and Vodafone Group plc

GlaxoSmithKline plc (LON:GSK), Centrica PLC (LON:CNA) and Vodafone Group plc (LON:VOD) are the heavyweight holdings of Murray Income Trust plc (LON:MUT).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Murray Income Trust (LSE: MUT) announced its annual results last month. The board lifted the dividend by 3.4% to record 30 years of unbroken growth. At a current share price of 762p the trailing yield is 4%.

Picking great dividend shares has helped Murray Income outperform the FTSE All-Share Index over the past three, five and 10 years.

Let’s take a look at the trust’s current top three holdings: GlaxoSmithKline (LSE: GSK), Centrica (LSE: CNA) and Vodafone (LSE: VOD) (NASDAQ: VOD.US).

GlaxoSmithKline

GlaxoSmithKline (GSK) is a longstanding favourite of income investors. The UK’s top pharmaceuticals group has continued to increase its dividend despite the recent years of patent expiries and threat from generic rivals.

Free cash flow has been tight of late but GSK has a strong late-stage pipeline of new treatments, and recent agreements to sell non-core drinks brands Lucozade and Ribena, and thrombosis brands Arixtra and Fraxiparine, will bring in handy cash of £2bn.

Analysts are forecasting a 4.2% increase in the dividend for the current year, giving a 5% yield at a recent share price of 1,540p.

Centrica

Shares of Centrica, the owner of British Gas, have come under the cosh recently as a result of Ed Miliband’s proposal to break up the ‘Big Six’ utilities and cap energy bills. High-profile fund manager Neil Woodford — Centrica’s largest shareholder — has slammed the proposal as “economic vandalism”.

Now could be a good time to invest in Centrica, if you believe Labour’s proposal is unworkable on the basis that, as Woodford says: “If Centrica and SSE cannot make any money supplying electricity to the retail market then they won’t supply it. The lights will go off …”

Centrica has been a reliable dividend payer, and the recent drop in the share price has pushed up the yield. With the shares trading at 368p, and analysts forecasting a 6% rise in this year’s dividend, the prospective income is 4.7%.

Vodafone

There was big news last month with the coming to fruition of Vodafone’s long-mooted sale of its 45% interest in US company Verizon Wireless to Verizon Communications.

On announcing the sale — worth a whopping $130bn — Vodafone said “The Board …  intends to increase the total 2014 financial year dividend per share by 8% to 11p”. At a recent share price of 217p that represents a yield of 5.1%.

Such an event as the game-changing sale of Verizon Wireless inevitably leads to some uncertainty. However, as far as the dividend is concerned, Vodafone has said that after the upcoming 11p a share payout, the board “intends to grow [the dividend] annually thereafter”.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> G A Chester does not own any shares mentioned in this article. The Motley Fool has recommended shares in GlaxoSmithKline and Vodafone.

More on Investing Articles

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Why Warren Buffett fears AI – and where savvy investors could spot an opportunity

Warren Buffett is cautious about AI but this Fool thinks the technology could present unique opportunities for forward-thinking investors.

Read more »

Storytelling image of a multiethnic senior couple in love - Elderly married couple dating outdoors, love emotions and feelings
Investing Articles

Is the 12.3% yield on this UK dividend stock too good to be true?

The impressive double-digit yield on this dividend stock recently grabbed the attention of our writer. But how sustainable is it?

Read more »

Investing Articles

2 dividend growth stocks analysts think are strong buys right now

Growth stocks that also distribute cash offer investors the best of both worlds. Stephen Wright looks at two that have…

Read more »

Investing Articles

I asked Anthropic’s Claude for the best FTSE 100 stock to buy right now. I’m impressed with what it said

Can artificial intelligence identify the best FTSE 100 stock to buy right now? Stephen Wright tried it out – and…

Read more »

Investing Articles

£1k in savings? Here’s how investors can aim to turn that into a £9,600-a-year second income

Harvey Jones invests small, regular sums in FTSE 100 dividend stocks in an attempt to build a second income stream…

Read more »

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

5 investment trusts to consider for a new 2025 ISA

The biggest challenge when starting an ISA is choosing which stocks to buy. Investment trusts can make it a whole…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

Have I left it too late to buy Nvidia shares?

When the whole world was racing to buy Nvidia shares, Harvey Jones decided they were overhyped. Does the recent dip…

Read more »

Dividend Shares

I asked ChatGPT to pick me the best passive income stock. Here’s the result!

Jon Smith tries to make friends with ChatGPT and critiques the best passive income pick the AI tool suggested for…

Read more »